The Global Newborn Screening Market is forecasted to reach USD 2.27 Billion by 2027, according to a new report by Emergen Research. Newborn screening tests in infants check for developmental, metabolic, and genetic abnormalities. Newborn screening includes more than 30 diseases and conditions.
At Emergen research we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.